Mycobacterium bovis BCG was introduced as an antituberculosis (anti-TB) vaccine over 80 years ago and has since become one of the most widely used of all vaccines (11,40). Approximately 100 million children worldwide are vaccinated with BCG each year (40). BCG vaccination of infants affords 80% protection against TB meningitis and against disseminated or miliary TB. However, it is variably effective against pulmonary disease at all ages or against the reactivation of latent pulmonary infection in adults (10,37,40). Consequently, in spite of extensive BCG vaccination in many parts of the world, TB rates are high, with about 8 million cases and 2 million deaths annually (32). South Africa ranks eighth in the world for TB incidence, with a rate of approximately 600 cases per 100,000 population (39). Because TB is endemic in South Africa, infants are vaccinated with BCG (Danish strain) shortly after birth. Even with Ͼ95% BCG vaccination coverage, the rate of TB disease in babies remains very high, exceeding 2% per year among children under 2 years old in some areas (13).Little is known about the immune response of human neonates to mycobacteria prior to vaccination with BCG. Ota and coworkers have reported low levels of gamma interferon (IFN-␥), interleukin 5 (IL-5), and IL-13 following the stimulation of cord blood cells with a purified protein derivative of tuberculin (28). Another study that assessed the responses of cord blood to mycobacteria found low levels of secreted IFN-␥, IL-10, and IL-5 following incubation with BCG (16). However, it has not been clear which cells produce these cytokines and how IFN-␥ is induced in the naïve host prior to exposure to mycobacterial antigens and the stimulation of an acquired T-cell response. To further explore the infant immune response prior to vaccination with BCG, we incubated cord blood mononuclear cells (CBMC) and purified CD14 ϩ cells in vitro with the Danish strain of BCG and quantified the IFN-␥, IL-12, IL-10, IL-4, IL-5, and IL-13 secreted into the culture supernatants. Furthermore, to identify the cell types producing these cytokines, intracellular CD4 ϩ and CD8 ϩ T-cell IFN-␥ and IL-10, intracellular CD56ϩ NK cell IFN-␥, and intracellular CD14 ϩ monocyte IFN-␥ and IL-10 were evaluated after the ex vivo incubation of whole cord blood with Danish BCG. The results were compared to the responses of the same cellular subsets in peripheral blood samples from 13-week-old babies vaccinated with BCG at birth. The data indicate that the Th1 cytokine response of the naïve host prior to BCG vaccination was confined to cells of the innate immune system and did not involve T-cell responses. However, post-BCG vaccination, while a similar profile of cytokines was produced, it was T cells that produced IFN-␥, thus providing a larger and more sustainable source of immune stimulation.
MATERIALS AND METHODSParticipants. Umbilical cord blood was collected from elective caesarean donors at full term (38 to 39 weeks) to avoid any possible effects of labor. A total